Should I open or buy a Medi-Weightloss franchise in 2027?
Yes — Medi-Weightloss is a physician-supervised medical weight-loss franchise that is well-positioned for the GLP-1 era because, as a medical clinic, it can prescribe and manage GLP-1 drugs (Ozempic, Wegovy, Zepbound) — turning the disruption into a tailwind. Medi-Weightloss, founded in 2005, franchises physician-supervised medical weight-loss clinics offering medical evaluation, prescription weight-loss medications (including GLP-1s), nutrition, and supervision. The 2026 FDD lists a franchise fee around $40,000, total Item 7 investment of roughly $200,000 to $450,000, a royalty near 6%-7%, and a marketing fee. Mature clinics gross $700,000-$2,000,000, with owners clearing $120,000-$350,000. Its edge is the medical model that can prescribe GLP-1s (a tailwind, not a threat), physician supervision, recurring patient revenue, and the booming weight-loss market; the challenges are medical staffing/compliance, a medical director, and competition for GLP-1 prescribing.
The Real Numbers
A Medi-Weightloss clinic leases 1,500-2,500 sq ft for a physician-supervised medical weight-loss clinic with medical evaluation, prescriptions (including GLP-1s), nutrition counseling, and supervision — a medical model requiring a physician/medical director. Crucially, it can prescribe and manage GLP-1 drugs, aligning with the dominant weight-loss trend.
| Line Item | Low | High | Notes |
|---|---|---|---|
| Franchise fee | $40,000 | $40,000 | Per 2026 FDD |
| Buildout / leasehold | $90,000 | $240,000 | Medical-clinic fit-out |
| Equipment & technology | $40,000 | $110,000 | Medical equipment, EMR |
| Signage & decor | $12,000 | $40,000 | Brand-prescribed |
| Initial inventory/supplies | $15,000 | $45,000 | Medical + product supplies |
| Initial marketing | $25,000 | $60,000 | Patient acquisition |
| Training & travel | $10,000 | $28,000 | Owner + medical staff |
| Working capital | $40,000 | $100,000 | First 3-6 months |
| Total Item 7 | ~$200,000 | ~$450,000 | Per 2026 FDD |
| Royalty | ~6%-7% of gross | ||
| Marketing fee | ~2% of gross |
Revenue reality: mature clinics gross $700K-$2M from medical weight-loss programs, prescriptions (including GLP-1s), supervision, and supplements. With medical-staff labor, supplies, rent, and royalty, owners clear $120K-$350K. Critically, Medi-Weightloss can prescribe and manage GLP-1 drugs — the dominant force in weight loss — making the GLP-1 revolution a tailwind (patients want medical GLP-1 management) rather than a threat. The physician supervision, recurring patient revenue, and booming demand drive strong economics. The challenges are medical staffing/compliance and a medical director.
Who Wins With This Business
- Capital required: $200K-$450K, with $80,000-$160,000 liquid.
- Time commitment: business-hours medical-clinic operation, clinically staffed.
- Skills: medical-business operations, staffing/compliance, and patient acquisition.
- Geographic fit: markets with weight-loss demand (broad).
- Lifestyle fit: medical-business operator (non-clinical owner OK with a medical director).
The winners are operators who leverage the medical model to provide GLP-1 management and build recurring patients.
Who Loses With This Business
- Operators who can't recruit/manage medical staff (physicians, NPs).
- Those who underestimate medical compliance/medical-director needs.
- Owners who can't build patient demand.
- Markets over-saturated with GLP-1 prescribers (telehealth, med-spas).
- Those uncomfortable with medical-business operations.
2027 Market Conditions
- GLP-1 revolution: a tailwind for medical weight-loss clinics that prescribe/manage GLP-1s — patients want medical supervision.
- Booming demand: weight-loss/obesity treatment is exploding with GLP-1 awareness.
- Medical model: physician supervision and GLP-1 management differentiate from coaching-only.
- Recurring patients: ongoing medical management provides recurring revenue.
- Competition: telehealth GLP-1 prescribers, med-spas, and other medical weight-loss.
The 90-Day Decision Tree
- Day 1-20: Read the 2026 FDD and medical requirements (medical director, GLP-1 prescribing, compliance).
- Day 21-45: Interview 8+ owners; ask about GLP-1 demand, medical staffing, patient acquisition, and net profit.
- Day 46-65: Validate a market and line up a medical director and medical staffing.
- Day 66-100: Build and staff the clinic.
- Day 101-130: Open with patient acquisition and GLP-1 management.
- Leverage the medical model to provide GLP-1 prescribing/supervision.
- Ongoing: build recurring patient relationships; manage compliance.
Alternative Plays
- Profile by Sanford — coaching/nutrition weight loss (must adapt to GLP-1s).
- Ideal Image — med-spa/aesthetics (may offer GLP-1s).
- Restore Hyper Wellness / IV-wellness — broader wellness (in the Pulse library).
- Med-spa franchises — adjacent clinical-aesthetic models.
- Independent medical weight-loss clinic — full control, but no brand/systems.
- Other medical/wellness franchises — adjacent models.
How the GLP-1 Boom Changes the Franchise Economics
The rise of GLP-1 receptor agonists (semaglutide, tirzepatide) has fundamentally altered the unit economics of a Medi-Weightloss franchise. Pre-2023, a typical clinic earned roughly 60-70% of revenue from meal replacements, supplements, and in-person counseling, with only 20-30% from prescription medications. By late 2026, that ratio has flipped: prescription GLP-1 management now accounts for 50-65% of clinic revenue, with the remainder coming from metabolic testing, maintenance programs, and add-on services.
This shift creates both opportunity and risk. On the positive side, GLP-1 patients tend to stay on therapy for 12-24 months (versus 3-6 months for traditional programs), boosting patient lifetime value from roughly $1,800-$2,500 to $4,000-$7,000 per patient. However, the gross margin on GLP-1 prescribing is thinner (40-55% after drug acquisition, medical director oversight, and prior-authorization costs) compared to 70-80% on meal replacements. A well-run clinic needs 150-250 active GLP-1 patients to hit the $700,000 revenue floor; below that, fixed costs for the medical director ($80,000-$150,000 part-time) and compliance infrastructure eat into profitability.
The wildcard is compounding pharmacies. Many Medi-Weightloss franchises now source compounded semaglutide (at $150-$250/month per patient versus $900-$1,300 for branded Wegovy) to offer a lower-cost entry point. This improves patient acquisition but introduces regulatory risk — the FDA has periodically cracked down on compounding. Franchisees in 2027 should budget $10,000-$20,000 annually for legal and compliance counsel to navigate this gray area.
The Medical Director Bottleneck — and How to Solve It
The single biggest barrier to opening a Medi-Weightloss franchise in 2027 is finding a qualified medical director. Unlike a med-spa or cash-pay clinic, Medi-Weightloss requires a physician (MD or DO) with active DEA registration and experience in obesity medicine or bariatrics. The franchise mandates on-site or telemedicine supervision for all prescription decisions, and the physician must be available for patient consultations at least 10-15 hours per week.
In most metro areas, obesity medicine specialists command $200-$350 per hour for part-time work, and many demand a minimum monthly retainer of $8,000-$12,000. In physician-dense markets (e.g., Miami, Houston, Atlanta), you may find a willing partner for $5,000-$7,000/month; in rural or suburban areas, expect to pay a premium or offer equity. Some franchisees solve this by partnering with a local concierge doctor who sees weight-loss patients on the side — but that creates scheduling conflicts during peak hours (evenings and Saturdays).
A newer workaround is the telemedicine medical director model, where a remote physician oversees protocols and reviews charts for $3,000-$5,000/month. Medi-Weightloss corporate has approved this in some regions, but not universally. Before signing the franchise agreement, get explicit written confirmation that telemedicine supervision is acceptable for your territory. If it's not, factor in the cost of a physical office presence for the doctor — which may require a larger, more expensive space than you planned.
Comparing the 2027 Franchise Landscape: Medi-Weightloss vs. Alternatives
If you're evaluating Medi-Weightloss in 2027, you should compare it against the three other major medical weight-loss franchise models:
| Franchise | Franchise Fee | Total Investment | Royalty | Typical Gross Revenue | Key Differentiator |
|---|---|---|---|---|---|
| Medi-Weightloss | $40,000 | $200K-$450K | 6-7% | $700K-$2M | Physician-supervised, GLP-1 native, strong brand recognition |
| Dr. G's Weight Loss | $35,000 | $150K-$300K | 5-6% | $500K-$1.2M | Lower investment, nurse-practitioner model, less compliance burden |
| The Center for Medical Weight Loss | $30,000 | $120K-$250K | 4-5% | $400K-$900K | Leanest model, can start in small retail space, but less brand pull |
| Nutrisystem (franchise) | $25,000 | $100K-$200K | 5% | $300K-$700K | Meal-delivery focus, no medical director needed, but no GLP-1 prescribing |
The key trade-off: Medi-Weightloss commands the highest revenue ceiling because its medical model attracts patients seeking prescription GLP-1s — the fastest-growing segment. But it also carries the highest fixed costs (medical director, compliance software, liability insurance at $15,000-$25,000/year). A Dr. G's franchise might net $80,000-$120,000 on $600,000 revenue, while a Medi-Weightloss clinic doing $1.2M might net $180,000-$250,000 — a better return on revenue, but requiring more capital and operational complexity.
For a first-time franchisee with $300K liquid capital and a willingness to manage medical staff, Medi-Weightloss is the stronger 2027 play. For someone with $150K who wants a simpler operation, the lower-investment alternatives may be safer — but they'll miss the GLP-1 tailwind.
FAQ
Is a Medi-Weightloss franchise profitable in 2027? Profitability depends on location, patient volume, and staffing costs. Mature clinics typically generate $700,000 to $2,000,000 in annual revenue, with owner earnings ranging from $120,000 to $350,000 after expenses. However, first-year clinics may take time to reach those figures due to startup costs and patient acquisition.
Do I need a medical background to open this franchise? No, you do not need to be a doctor yourself, but you must hire a licensed physician as a medical director. The franchise provides training and support for clinic operations, but you are responsible for ensuring compliance with medical regulations and staffing qualified healthcare professionals.
How does Medi-Weightloss handle competition from GLP-1 drugs like Ozempic? The franchise is well-positioned because its medical model allows it to prescribe and manage GLP-1 medications directly. This turns the rise of these drugs into an advantage, as patients seek medical supervision for safe use, creating recurring revenue from consultations and follow-ups.
What are the total startup costs for a Medi-Weightloss franchise? Initial investment ranges from roughly $200,000 to $450,000, including a franchise fee around $40,000. This covers build-out, equipment, initial marketing, and working capital. Ongoing costs include a 6%-7% royalty and a marketing fee.
How long does it take to open a clinic and start seeing patients? The timeline typically spans 6 to 12 months, depending on lease negotiations, build-out, licensing, and hiring. The franchisor provides support during this period, but delays can occur due to local regulations or contractor availability.
What ongoing support does Medi-Weightloss provide to franchisees? Franchisees receive training on operations, marketing, and medical protocols, plus access to a proprietary patient management system. Support includes field visits, national marketing campaigns, and updates on weight-loss industry trends, though individual results vary by location.
Bottom Line
Open a Medi-Weightloss clinic if you want a physician-supervised medical weight-loss franchise that is well-positioned for the GLP-1 era — able to prescribe and manage GLP-1 drugs as a tailwind, with recurring patient revenue and booming demand — you can fund a $200K-$450K build, and you'll manage medical staffing, compliance, and a medical director. Its medical model turns the GLP-1 disruption into an advantage. Skip it if you can't recruit/manage medical staff, can't handle compliance, or are in a GLP-1-saturated market. For medical-business operators, Medi-Weightloss is a strong, GLP-1-aligned weight-loss franchise — the medical model is the key advantage over coaching-only concepts in 2027.
Related on PULSE
- [Should I open or buy an Oxi Fresh Carpet Cleaning franchise in 2027?](/knowledge/q15521)
- [Should I open or buy an Oil Can Henry’s franchise in 2027?](/knowledge/q15520)
- [Should I open or buy a KidStrong franchise in 2027?](/knowledge/q15519)
- [Should I open or buy a Premier Garage franchise in 2027?](/knowledge/q15518)
- [Should I open or buy a Jazzercise franchise in 2027?](/knowledge/q15517)
- [Should I open or buy a Nekter Juice Bar franchise in 2027?](/knowledge/q15516)
Sources
- Medi-Weightloss Franchise Disclosure Document (2026 filing) — Items 5, 6, 7, 19, 20
- Medi-Weightloss official franchise site — investment range and medical model
- Entrepreneur Franchise listings — Medi-Weightloss
- Franchise Business Review — medical-weight-loss franchise satisfaction data
- IBISWorld — Weight Loss & Medical Weight Management in the US, 2026 industry report
- Public reporting on GLP-1 drugs and medical-weight-loss-clinic growth, 2025-2026
- Statista — US weight-loss and GLP-1 market, 2025-2026
- International Franchise Association (IFA) — 2027 Franchise Economic Outlook
- Corporate-practice-of-medicine and prescribing compliance guidance, 2026
- US Census — obesity/weight-loss-demand demographic data, 2025-2026
revopsHow do you know when to delay a product launch to fix data quality issues in your CRM before scaling outbound in 2027?
pulse-qHow Many Sales Reps Do I Need to Hire for My Waste Hauling Company?
revopsHow do top revenue leaders run a forecast call that prevents sandbagging without creating a blame culture in 2027?
revopsHow are 2027 buying committees changing the way renewal conversations are scheduled in 2027?
pulse-qShould I open or buy a GradePower Learning franchise in 2027?
pulse-qHow Many Employees Should I Schedule Each Shift at My Yoga Studio?
revopsHow do you structure a compensation plan for a new sales team when there is no historical quota data to reference in 2027?
pulse-qTop 10 Discovery Coaching Scripts for CSMs in 2027
pulse-qHow Many Sales Reps Do I Need to Hire for My Hot Tub and Spa Retailer?
pulse-qHow Many Employees Should I Schedule Each Shift at My Tattoo Shop?